APDN Annual Cash & Cash Equivalents
$6.43 M
-$720.70 K-10.08%
30 September 2024
Summary:
As of January 23, 2025, APDN annual cash & cash equivalents is $6.43 million, with the most recent change of -$720.70 thousand (-10.08%) on September 30, 2024. During the last 3 years, it has fallen by -$123.80 thousand (-1.89%). APDN annual cash & cash equivalents is now -57.73% below its all-time high of $15.22 million, reached on September 30, 2022.APDN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APDN Quarterly Cash And Cash Equivalents
$6.43 M
-$4.01 M-38.41%
01 September 2024
Summary:
As of January 23, 2025, APDN quarterly cash and cash equivalents is $6.43 million, with the most recent change of -$4.01 million (-38.41%) on September 1, 2024. Over the past year, it has increased by +$3.28 million (+104.19%). APDN quarterly cash and cash equivalents is now -57.73% below its all-time high of $15.22 million, reached on September 30, 2022.APDN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APDN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.1% | +104.2% |
| 3 y3 years | -1.9% | -47.7% |
| 5 y5 years | +1050.5% | -47.7% |
APDN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.7% | at low | -57.7% | +134.0% |
| 5 y | 5-year | -57.7% | +1050.5% | -57.7% | +134.0% |
| alltime | all time | -57.7% | -57.7% |
Applied DNA Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | $6.43 M(-10.1%) | - |
| Sept 2024 | - | $6.43 M(-38.4%) |
| June 2024 | - | $10.44 M(+231.5%) |
| Mar 2024 | - | $3.15 M(-6.2%) |
| Dec 2023 | - | $3.36 M(-53.0%) |
| Sept 2023 | $7.15 M(-53.0%) | $7.15 M(-33.5%) |
| June 2023 | - | $10.76 M(-12.5%) |
| Mar 2023 | - | $12.29 M(-4.6%) |
| Dec 2022 | - | $12.88 M(-15.4%) |
| Sept 2022 | $15.22 M(+132.1%) | $15.22 M(+225.0%) |
| June 2022 | - | $4.68 M(-28.1%) |
| Mar 2022 | - | $6.51 M(+137.0%) |
| Dec 2021 | - | $2.75 M(-58.1%) |
| Sept 2021 | $6.55 M(-15.8%) | $6.55 M(-46.2%) |
| June 2021 | - | $12.17 M(-12.6%) |
| Mar 2021 | - | $13.93 M(+228.3%) |
| Dec 2020 | - | $4.24 M(-45.5%) |
| Sept 2020 | $7.79 M(+1293.0%) | $7.79 M(-28.7%) |
| June 2020 | - | $10.93 M(+26.1%) |
| Mar 2020 | - | $8.66 M(0.0%) |
| Dec 2019 | - | $8.66 M(+1449.7%) |
| Sept 2019 | $559.00 K(-66.3%) | $559.00 K(+10.2%) |
| June 2019 | - | $507.10 K(-67.1%) |
| Mar 2019 | - | $1.54 M(-50.9%) |
| Dec 2018 | - | $3.14 M(+89.1%) |
| Sept 2018 | $1.66 M(-43.9%) | $1.66 M(-34.0%) |
| June 2018 | - | $2.51 M(-32.2%) |
| Mar 2018 | - | $3.71 M(-22.1%) |
| Dec 2017 | - | $4.76 M(+61.0%) |
| Sept 2017 | $2.96 M(-33.9%) | $2.96 M(+23.2%) |
| June 2017 | - | $2.40 M(-40.2%) |
| Mar 2017 | - | $4.02 M(-40.0%) |
| Dec 2016 | - | $6.70 M(+49.6%) |
| Sept 2016 | $4.48 M(-38.7%) | $4.48 M(-36.8%) |
| June 2016 | - | $7.09 M(-27.6%) |
| Mar 2016 | - | $9.79 M(-21.0%) |
| Dec 2015 | - | $12.38 M(+69.3%) |
| Sept 2015 | $7.31 M(+424.9%) | $7.31 M(-31.9%) |
| June 2015 | - | $10.73 M(+990.5%) |
| Mar 2015 | - | $984.00 K(-65.7%) |
| Dec 2014 | - | $2.87 M(+106.1%) |
| Sept 2014 | $1.39 M(-78.1%) | $1.39 M(-31.2%) |
| June 2014 | - | $2.03 M(+1.9%) |
| Mar 2014 | - | $1.99 M(-52.7%) |
| Dec 2013 | - | $4.20 M(-34.0%) |
| Sept 2013 | $6.36 M(+777.5%) | $6.36 M(+247.2%) |
| June 2013 | - | $1.83 M(-58.4%) |
| Mar 2013 | - | $4.41 M(+347.5%) |
| Dec 2012 | - | $984.40 K(+35.8%) |
| Sept 2012 | $724.80 K | $724.80 K(-42.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $1.26 M(+46.6%) |
| Mar 2012 | - | $856.60 K(-55.7%) |
| Dec 2011 | - | $1.94 M(-29.5%) |
| Sept 2011 | $2.75 M(>+9900.0%) | $2.75 M(>+9900.0%) |
| June 2011 | - | $12.50 K(-89.8%) |
| Mar 2011 | - | $122.80 K(-73.8%) |
| Dec 2010 | - | $468.30 K(+2560.8%) |
| Sept 2010 | $17.60 K(-91.7%) | $17.60 K(-18.5%) |
| June 2010 | - | $21.60 K(-78.2%) |
| Mar 2010 | - | $98.90 K(+1548.3%) |
| Dec 2009 | - | $6000.00(-97.2%) |
| Sept 2009 | $213.30 K(+56.4%) | $213.30 K(+1125.9%) |
| June 2009 | - | $17.40 K(+21.7%) |
| Mar 2009 | - | $14.30 K(-72.0%) |
| Dec 2008 | - | $51.10 K(-62.5%) |
| Sept 2008 | $136.40 K(+441.3%) | $136.40 K(-76.7%) |
| June 2008 | - | $585.20 K(0.0%) |
| Mar 2008 | - | $585.20 K(-30.8%) |
| Dec 2007 | - | $845.70 K(+3256.0%) |
| Sept 2007 | $25.20 K(-97.9%) | $25.20 K(-27.6%) |
| June 2007 | - | $34.80 K(-61.0%) |
| Mar 2007 | - | $89.20 K(-86.3%) |
| Dec 2006 | - | $653.10 K(-46.7%) |
| Sept 2006 | $1.23 M(+3827.2%) | $1.23 M(-36.6%) |
| June 2006 | - | $1.93 M(+2385.5%) |
| Mar 2006 | - | $77.70 K(-52.8%) |
| Dec 2005 | - | $164.50 K(+427.2%) |
| Sept 2005 | $31.20 K(+1633.3%) | $31.20 K(-97.4%) |
| June 2005 | - | $1.19 M(-59.9%) |
| Mar 2005 | - | $2.98 M(+4644.8%) |
| Dec 2004 | - | $62.70 K(+3383.3%) |
| Sept 2004 | $1800.00(-99.1%) | $1800.00(-99.1%) |
| Mar 2004 | - | $198.20 K(-68.3%) |
| Dec 2003 | - | $624.40 K(+222.7%) |
| Sept 2003 | $193.50 K(>+9900.0%) | $193.50 K(+146.2%) |
| June 2003 | - | $78.60 K(+203.5%) |
| Mar 2003 | - | $25.90 K(>+9900.0%) |
| Dec 2002 | - | $100.00(0.0%) |
| Sept 2002 | - | $100.00(0.0%) |
| June 2002 | - | $100.00(0.0%) |
| Mar 2002 | - | $100.00(0.0%) |
| Dec 2001 | $100.00(>+9900.0%) | $100.00(0.0%) |
| Sept 2001 | - | $100.00(>+9900.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) |
| Dec 1999 | $0.00(0.0%) | $0.00 |
| Dec 1998 | $0.00 | - |
FAQ
- What is Applied DNA Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Applied DNA Sciences?
- What is Applied DNA Sciences annual cash & cash equivalents year-on-year change?
- What is Applied DNA Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Applied DNA Sciences?
- What is Applied DNA Sciences quarterly cash and cash equivalents year-on-year change?
What is Applied DNA Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of APDN is $6.43 M
What is the all time high annual cash & cash equivalents for Applied DNA Sciences?
Applied DNA Sciences all-time high annual cash & cash equivalents is $15.22 M
What is Applied DNA Sciences annual cash & cash equivalents year-on-year change?
Over the past year, APDN annual cash & cash equivalents has changed by -$720.70 K (-10.08%)
What is Applied DNA Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APDN is $6.43 M
What is the all time high quarterly cash and cash equivalents for Applied DNA Sciences?
Applied DNA Sciences all-time high quarterly cash and cash equivalents is $15.22 M
What is Applied DNA Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, APDN quarterly cash and cash equivalents has changed by +$3.28 M (+104.19%)